| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_89b60e340c7765626013119f28c35bfd |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- |
| filingDate |
1998-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2000-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_405ab5851ff71494b1eb9cd9bd706f18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6727c1581f78ef559672284e805654d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db0d02e06abbd42dbc78de355d87eb9b |
| publicationDate |
2000-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
IT-1303252-B1 |
| titleOfInvention |
USE OF OTILONIUM BROMIDE AS AN NK2 ANTAGONIST AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101825610-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101825610-B |
| priorityDate |
1998-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |